PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $582,200 | +55.8% | 410,000 | +26.2% | 0.12% | +44.6% |
| Q2 2023 | $373,750 | +38.3% | 325,000 | +27.5% | 0.08% | -11.7% |
| Q1 2023 | $270,300 | +97.6% | 255,000 | +183.3% | 0.09% | +80.8% |
| Q4 2022 | $136,800 | -28.4% | 90,000 | 0.0% | 0.05% | +10.6% |
| Q3 2022 | $191,000 | +57.9% | 90,000 | 0.0% | 0.05% | +80.8% |
| Q2 2022 | $121,000 | -28.4% | 90,000 | +12.5% | 0.03% | -21.2% |
| Q1 2022 | $169,000 | +14.2% | 80,000 | +100.0% | 0.03% | +26.9% |
| Q4 2021 | $148,000 | -34.2% | 40,000 | -11.1% | 0.03% | -36.6% |
| Q3 2021 | $225,000 | -1.3% | 45,000 | +28.6% | 0.04% | -6.8% |
| Q2 2021 | $228,000 | -5.4% | 35,000 | 0.0% | 0.04% | -13.7% |
| Q1 2021 | $241,000 | -40.9% | 35,000 | -12.5% | 0.05% | -45.2% |
| Q4 2020 | $408,000 | -17.2% | 40,000 | -71.6% | 0.09% | -30.6% |
| Q3 2020 | $493,000 | – | 140,809 | +27.1% | 0.13% | – |
| Q1 2020 | $0 | – | 110,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |